[{"data": {"name": "Atypical and Conventional Antipsychotic Drugs in Treatment-Naive First-Episode Schizophrenia: A 52-Week Randomized Trial of Clozapine Vs Chlorpromazine", "@type": "ScholarlyArticle", "genre": "journal-article", "author": [{"name": "Jeffrey A Lieberman", "@type": "Person"}, {"name": "Michael Phillips", "@type": "Person"}, {"name": "Hongbin Gu", "@type": "Person"}, {"name": "Scott Stroup", "@type": "Person"}, {"name": "Peiyan Zhang", "@type": "Person"}, {"name": "Lan Kong", "@type": "Person"}, {"name": "Zhongfu Ji", "@type": "Person"}, {"name": "Gary Koch", "@type": "Person"}, {"name": "Robert M Hamer", "@type": "Person"}], "@context": "http://schema.org/", "encoding": [{"@type": "MediaObject", "contentUrl": "https://www.nature.com/articles/1300157.pdf", "encodingFormat": "application/pdf"}], "publisher": {"name": "Springer Nature", "@type": "Organization"}, "identifier": [{"@type": "PropertyValue", "value": "10.1038/sj.npp.1300157", "propertyID": "DOI"}, {"@type": "PropertyValue", "value": "CCeAECWYrEokJ-CT6zTBgcZeG8D-CDLK7Va6CuMrG-CRb9bZpdaQF7m", "propertyID": "ISCC"}], "datePublished": "2002-01-08"}, "schema": "schema.org", "mediatype": "application/ld+json"}]